Expression of thioredoxin reductase 1 (TrxR1) in gastric cancer and its effect on the growth of gastric cancer cells

doi:10.12047/j.cjap.5967.2020.070

Abstract

Abstract: Objective: To investigate the relationship between the expression of thioredoxin reductase 1 (TrxR1) in gastric cancer tissues and the survival time of patients with gastric cancer and its effect on the growth of gastric cancer cells. Methods: The expression level of TrxR1 mRNA in gastric cancer tissues and adjacent tissues of 76 patients was determined by real-time PCR assays, and the relationship between the mRNA expression level of TrxR1 and the clinicopathological characteristics and prognosis of gastric cancer patients was analyzed. Three gastric cancer tissues and adjacent tissues were randomly selected, and the expression of TrxR1 protein was detected by immunohistochemistry and Western blot. The expression levels of TrxR1 in human gastric cancer cells line and gastric mucosa epithelial cells were determined by Western blot and quantitative real-time PCR assays. Then, AGS cells were transfected with siRNA sequences to silence the expression of TrxR1. AGS cells were divided into 3 groups according to different processing negative control group: transfected with NC-siRNA, TRXR1 siRNA interference group 1: transfected with TRXR1-siRNA1, TRXR1 siRNA interference 2 group: transfected with TRXR1-siRNA2. The expression of TrxR1 mRNA in AGS cells of each group was detected by Real-time PCR. The proliferation of AGS cells was determined by MTT and colony formation assays following TrxR1 silencing. Results: TrxR1 mRNA and protein expression levels in gastric cancer tissues were significantly up-regulated compared with adjacent tissues, and were mainly located in the cytoplasm. High expression of TrxR1 was associated with TNM stage and lymph node metastasis, and the overall survival time of patients with high expression of TrxR1 was shorter than those with low expression level. TrxR1 mRNA and protein in AGS cells of TRXR1-siRNA1 group and AGS cells of TRXR1-siRNA2 group were significantly reduced compared with NC-siRNA group (P＜0.05). And AGS cell clone formation and proliferation ability were decreased. Conclusion: The high expression of TrxR1 in gastric cancer tissues indicates poor prognosis of patients, and the silencing of TrxR1 can inhibit the proliferation of gastric cancer cells.

Key words: gastric cancer, thioredoxin reductase 1, prognosis, silencing, proliferation

CLC Number:

R735

FAN You-shou, QIU Zhi-sheng, ZHAO Ya-ping. Expression of thioredoxin reductase 1 (TrxR1) in gastric cancer and its effect on the growth of gastric cancer cells[J]. CJAP, 2020, 36(4): 324-329.

References

[1] 王凤杰, 宗星煜, 杜俊龙, 等. 二氢杨梅素对人胃癌MKN45细胞迁移和侵袭的影响及其机制[J]. 中国应用生理学杂志, 2019, 35(5): 428-432.
[2] Qiao W, Cao N, Yang L. MicroRNA-154 inhibits the growth and metastasis of gastric cancer cells by directly targeting MTDH[J]. Oncol lett, 2017, 14(3): 3268-3274.
[3] 吴涛, 段晓剑, 田宇, 等. 低氘环境对胃癌细胞生长影响的体外实验[J]. 中国应用生理学杂志, 2017, 33(1): 1-5.
[4] Chen G, Chen Q, Zeng F, et al. The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer [J]. Oncotarget, 2017, 8(70): 115270-115279.
[5] Lee JR, Roh JL, Lee SM, et al. Overexpression of glutathione peroxidase 1 predicts poor prognosis in oral squamous cell carcinoma [J]. J Cancer Res Clin Oncol, 2017, 143 (11): 2257-2265.
[6] Esen H, Feyzioglu B, Erdi F, et al. High thioredoxin reductase 1 expression in meningiomas undergoing malignant progression [J]. Brain Tumor Pathol, 2015, 32 (3): 195-201.
[7] Zhang Y, Chen F, Tai G, et al. TIGAR knockdown radiosensitizes TrxR1-overexpressing glioma in vitro and in vivo via inhibiting Trx1 nuclear transport [J]. Sci Rep, 2017, 7 (5): 42928.
[8] Pena CA, Gonzalez R, Lopez-Grueso MJ, et al. Redox regulation of metabolic and signaling pathways by thioredoxin and glutaredoxin in nitric oxide treated hepatoblastoma cells [J]. Redox Biol, 2015, 5: 418.
[9] Tóth D, BíróA, Varga Z, et al. Comparison of different lymph node staging systems in prognosis of gastric cancer: a bi-institutional study from Hungary [J]. Chin J Cancer Res, 2017, 29 (4): 323-332.
[10] LuJ, Holmgren A. The thioredoxin antioxidant system [J]. Free Radic Biol Med, 2014, 66: 75-87.
[11] McLoughlin MR, Orlicky DJ, Prigge JR, et al. TrxR1, Gsr, and oxidative stress determine hepatocellular carcinoma malignancy [J]. Proc Natl Acad Sci USA, 2019, 116 (23): 11408-11417.
[12] Zou P, Xia Y, Ji J, et al. Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer [J]. Cancer Lett, 2016, 375 (1): 114-126.
[13] 冉冬梅, 高丰厚. 非小细胞肺癌细胞中TrxR1的表达及其效应[J]. 临床与实验病理学杂志, 2015, 31 (2): 136-140.
[14] Esen H, Erdi F, Kaya B, et al. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades [J]. J Neurooncol, 2015, 121 (3): 451-458.
[15] Yin ZX, Hang W, Liu G, et al. PARP-1 inhibitors sensitize HNSCC cells to APR-246 by inactivation of thioredoxin reductase 1 (TrxR1) and promotion of ROS accumulation [J]. Oncotarget, 2018, 9 (2): 1885-1897.
[16] He W, Cao P, Xia Y, et al. Potent inhibition of gastric cancer cells by a natural compound via inhibiting TrxR1 activity and activating ROS-mediated p38 MAPK pathway [J]. Free Radic Res, 2019, 53 (1): 104-114.
[17] 邓堂刚, 周宇, 冯佩富, 等. 泛素-蛋白酶体通路介导细胞内c-Myc调控的研究进展[J].中国细胞生物学学报, 2017, 39: 488-495.
[18] 李金姑, 石淑卿, 林元. C-myc和cyclin D1在子宫内膜异位症中免疫反应性增强[J]. 中国组织化学与细胞化学杂志, 2017, 26 (2): 152-159.